Cardlytics Continues Profits Contraction In The Middle Of Deterioration Economics (NASDAQ: CDLX)

.Financial author recommends selling Cardlytics, Inc. due to decreasing device business economics, profits challenges, and also unfavorable financial patterns. Click for this CDLX update.